Radiodermatitis can be a dose-limiting side effect resulting in cancer treatment delays or even cancer treatment cessation, as well as significant pain and limitation of usual lifestyle activities. Radiodermatitis is the integumentary system's response to exposure to ionizing radiation, and 95% of patients have reported some degree of integumentary system reaction to radiotherapy. Short-term skin responses can range from erythematous rash to development of desquamation and necrosis. Late effects can appear months to years after radiation treatment and include pigmentation changes, telangiectasia, photosensitivity, fibrosis, atrophy, and delayed wound healing and other complications of surgery within the radiation treatment field.
ONS staff researchers and clinical specialists have exhaustively assessed evidenced-based research from comprehensive sources to provide you our best recommendations on Symptom Interventions for your patients.